Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
  
  The rules state that definitive UDT is reasonable and necessary in order to: 
 
- Identify a specific substance or metabolite that is inadequately detected by a presumptive UDT; 
- Definitively identify specific drugs in a large family of drugs; 
- Identify a specific substance or metabolite that is not detected by presumptive UDT such as fentanyl, 
meperidine, synthetic cannabinoids and other synthetic/analog drugs; 
- Identify drugs when a definitive concentration of a drug is needed to guide management (e.g., discontinuation 
of THC use according to a treatment plan); 
- Identify a negative, or confirm a positive, presumptive UDT result that is inconsistent with a patients self-
report, presentation, medical history, or current prescribed pain medication plan; 
- Rule out an error as the cause of a presumptive UDT result; 
- Identify non-prescribed medication or illicit use for ongoing safe prescribing of controlled substances; and 
- Use in a differential assessment of medication efficacy, side effects, or drug-drug interactions. 
 
Definitive UDT may be reasonable and necessary based on patient specific indications, including historical use, 
medication response, and clinical assessment, when accurate results are necessary to make clinical decisions. 
The clinicians rationale for the definitive UDT and the tests ordered must be documented in the patients 
medical record. 
 
You can find this information in Local Coverage Determination (LCD): Controlled Substance Monitoring and 
Drugs of Abuse Testing (L35006). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
The rules say that a pneumatic compression device (PCD) is medically necessary for the treatment of 
lymphedema or for the treatment of chronic venous insufficiency with venous stasis ulcers.  The beneficiary 
must have a diagnosis of lymphedema and have persistent, chronic and severe lymphedema as identified by the 
documented presence of at least one of the following clinical findings: marked hyperkeratosis with hyperplasia 
and hyperpigmentation, papillomatosis cutis lymphostatica, deformity of elephantiasis or skin breakdown with 
persisting lymphorrhea. Additionally, the lymphedema must be documented as persistent and unresponsive to 
other clinical treatment over the course of a required four-week trial. This includes regular and compliant use 
of an appropriate compression bandage system or compression garment to provide adequate graduated 
compression.  
 
The rules say that a pneumatic compressor with calibrated gradient pressure is not covered for the treatment of 
lymphedema of the extremities alone but may be covered for the treatment of lymphedema extending onto the 
chest, trunk and/or abdomen.  The requested compressor may be medically necessary if the member has 
lymphedema extending past the limits of a standard compression sleeve, and the chest, trunk and/or abdominal 
lymphedema has failed to improve with a four-week trial of conservative care. 
The rules also say that PCD related accessories (such as codes E0667 and E0668) are eligible for 
reimbursement only when the appropriate, related base PCDs (E0650, E0651, E0652, E0675) meets the 
applicable coverage criteria for that type of PCD. If the base PCD is not covered, related accessories are not 
eligible for reimbursement. Claims for related items will be denied as not reasonable and necessary. 
You can find this information in the Local Coverage Determination (LCD) for Pneumatic Compression 
Devices (L33829). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that TMS of the brain for severe MDD, single or recurrent episode, is considered medically 
reasonable and necessary for up to six weeks3,5,6,16-19 when the following criteria are met: 
 
    The patient has a confirmed diagnosis of severe MDD as defined by the current DSM. 
    AND 
    The patient has demonstrated a failure of one or more trials of a pharmacological medication and/or 
demonstrates an intolerance to psychopharmacologic medications as defined in the definition section above. 
    AND 
    The order for TMS procedure is written by a psychiatrist (MD or DO), who has examined the patient face to 
face and reviewed the record.20 
 
You can find this information in the Local Coverage Determination (LCD) Transcranial Magnetic Stimulation 
(TMS) in the Treatment of Adults with Major Depressive Disorder L34998. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that the following is a list of suppliers who frequently attempt to enroll in Medicare but are not 
eligible to do so. (This list is not all-inclusive, however.). If the contractor receives an enrollment application 
from any of these individuals or entities, the contractor shall deny the application with the exception of entities 
eligible to enroll using the Form CMS-20134, which is specific to the furnishing of MDPP services. 
     Acupuncturist 
You can find this rule in the Medicare Program Integrity Manual Chapter 10.2.8 - Providers/Suppliers Not 
Eligible to Enroll. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract also says that acupuncture services are not covered when solely provided by an independent 
acupuncturist. You can find this information on pages 59 and 60 of the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on page 47 of the Plan's 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on page 69 of the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that Chronic Wounds are defined as wounds that do not respond to standard wound treatment for 
at least a 30-day period during organized comprehensive conservative therapy. Application of a skin substitute 
graft for lower extremity chronic wound (DFU and VLU) will be covered when the following conditions are 
met for the individual patient: 
 Presence of neuropathic diabetic foot ulcer(s) having failed to respond to documented conservative 
wound-care measures of greater than four weeks, during which the patient is compliant with 
recommendations, and without evidence of underlying osteomyelitis or nidus of infection. 
 Presence of a venous stasis ulcer for at least 3 months but unresponsive to appropriate wound care for at 
least 30 days with documented compliance. 
 Presence of a full thickness skin loss ulcer that is the result of abscess, injury or trauma that has failed to 
respond to appropriate control of infection, foreign body, tumor resection, or other disease process for a 
period of 4 weeks or longer. 
 
In all wound management the ulcer must be free of infection and underlying osteomyelitis with documentation 
of the conditions that have been treated and resolved prior to the institution of skin substitute therapy. You can 
find this rule in the Local Coverage Determination for the Application of Bioengineered Skin Substitutes to 
Lower Extremity Chronic Non-Healing Wounds, L35041. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 102-104 of the Plans 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
Molecular diagnostic tests used to assist in risk stratification of melanoma patients are covered when ALL of 
the following are true: 
1. The patient has a personal history of melanoma AND: 
1. Either: 
1. Has Stage T1b and above OR 
2. Has T1a with documented concern about adequacy of microstaging 
2. Is undergoing workup or being evaluated for treatment, AND 
3. Does not have metastatic disease AND 
4. Presumed risk for a positive Sentinel Lymph Node Biopsy (SLNB) based on clinical, 
histological, or other information is >5% AND 
5. Has a disease stage, grade, and Breslow thickness (or other qualifying conditions) within the 
intended use of the test 
You can find this information in the Centers for Medicare and Medicaid Services, Local Coverage 
Determination (LCD): MolDX: Melanoma Risk Stratification Molecular Testing (L37748). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that a fluid circulating cold pad with pump (E0218) will be denied as not reasonable and 
necessary. You can find this rule in the Local Coverage Determination (LCD) for Cold Therapy, L33735. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
  
  The rules say that ambulance services are only covered when the patient's clinical condition is such that other 
methods of transport are contraindicated. You can find this rule at 42 CFR Section 410.40(e). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
 
The rules also say that coverage for initial therapy must document failed standard anticholinergic drug therapy 
or that the patient demonstrates intolerance to the anticholinergic drug therapy despite best attempts at 
management of the most common side effects of such therapy, such as dry mouth and constipation. You can 
find this information in Local Coverage Article: Billing and Coding: Posterior Tibial Nerve 
Stimulation Coverage (A55104). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that no provider or supplier shall receive payment for services furnished to a Medicare 
beneficiary unless the provider or supplier is enrolled in the Medicare program. You can find this information 
in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-08, Medicare 
Program Integrity Manual, Chapter 10, Section 10.1.2.  
 
Licensed Professional Counselors frequently attempt to enroll in Medicare but are not eligible to do so; no 
statute permits them to bill Medicare. You can find this information in the Centers for Medicare and Medicaid 
Services, Internet Only Manual, Publication 100-08, Medicare Program Integrity Manual, Chapter 10, Section 
6.2.1.  
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will pay for durable medical equipment that is mainly used to serve a medical 
purpose. Items such as hospital beds, respirators, wheelchairs and crutches are examples of equipment that are 
clearly used for medical purposes. Medicare will not pay for: 
 
1. Equipment that is primarily and customarily used for nonmedical purposes. Examples include air 
conditioners, humidifiers, dehumidifiers and electric air cleaners; 
2. Equipment used for a patients comfort or for the convenience of a person caring for the patient. Examples 
include elevators, stairway elevators, physical fitness equipment and self-help devices such as grab bars. You 
can find these rules in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-
02, Medicare Benefit Policy Manual, Chapter 15, Section 110.1.  
 
A seat lift mechanism is covered if all of the following criteria are met: 
 
The beneficiary must have severe arthritis of the hip or knee or have a severe neuromuscular disease. 
The seat lift mechanism must be a part of the treating practitioners course of treatment and be prescribed to 
effect improvement, or arrest or retard deterioration in the beneficiary's condition. 
The beneficiary must be completely incapable of standing up from a regular armchair or any chair in their 
home. (The fact that a beneficiary has difficulty or is even incapable of getting up from a chair, particularly a 
low chair, is not sufficient justification for a seat lift mechanism. Almost all beneficiaries who are capable of 
ambulating can get out of an ordinary chair if the seat height is appropriate and the chair has arms.) 
Once standing, the beneficiary must have the ability to ambulate. 
 
You can find this information in the Local Coverage Determination (LCD) Seat Lift Mechanisms L33801. 
 
Side rails (E0305, E0310) or safety enclosures (E0316) are covered when they are required by the beneficiary's 
condition and they are an integral part of, or an accessory to, a covered hospital bed. 
 
You can find this information in the Local Coverage Determination (LCD) Hospital Beds And Accessories 
L33820.  
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.